First-in-class drug may be effective against therapy-resistant breast cancer
University of Texas Southwestern’s Harold C. Simmons Comprehensive Cancer Center (Dallas, TX, USA) researchers have demonstrated that a first-in-class molecule can prevent breast cancer growth in murine and patient-derived models, when traditional therapies stop working.
Please sign in or register for FREE
Sign in to MedChemNet
Register to MedChemNet
MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.